หน้าแรก
ค้นหา
No more cytoreductive nephrectomies for metastatic kidney cancer
A. Bex
แสดงข้อมูลเพิ่มเติม 1
No more cytoreductive nephrectomies for metastatic kidney cancer
Cytoreductive Surgery in the Era of Targeted Therapy for Kidney Cancer
Dr. Eber Discusses Patient Selection for Cytoreductive Nephrectomy in mRCC
UROwebinar: Management of Metastatic kidney cancer
Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma
Cytoreductive nephrectomy in mRCC
The Bottom Line: Practical Application of Clinical Trial Data to Advanced Renal Cell Carcinoma
Focus on Kidney: CARMENA and Renal Cell Carcinoma
Nephrectomy after complete response to immune checkpoint inhibitors for mRCC
Immunotherapy for metastatic RCC - EMPIRE Urology Lecture Series
Neo-Adjuvant and Adjuvant Therapy in Advanced Renal Cell Carcinoma - Upfront or Delayed Cytoreduc...
Metastatic Renal Cell Carcinoma
Patient selection for cytoreductive nephrectomy
Risk Stratification in Metastatic Renal Cell Carcinoma
Urology Teaching Collaborative | 6/2/20 | Dr. Robert Uzzo: Cytoreductive Nephrectomy in 2020
Kidney surgery may be unneeded in many intermediate-risk patients
Partial vs. Radical Nephrectomy for Kidney Cancer
Dr. Voss on Combining Dalantercept and Axitinib for Advanced Kidney Cancer
Dr. Rini on Practice Gaps and Barriers to Optimal Care of Renal Cell Carcinoma
Contrasting Cases: Nephrectomy
